GenNext and Agilent Unveil Groundbreaking Technology Integration to Accelerate High-Value Decision Making in Biopharmaceutical Research
Half Moon Bay, CA – September 10, 2024 – Today at CASSSS 2024, GenNext Technologies and Agilent announced a pioneering collaboration that promises to transform structural biology research for biopharmaceutical companies. The integration of GenNext’s AutoFox Protein Footprinting System with Agilent’s 6560 Ion Mobility Quadrupole Time-of-Flight (IM-QTOF) LC/MS System presents an unparalleled approach to detailed protein structure analysis and biomolecular interaction studies. This fusion of technology platforms enables biopharmaceutical researchers to achieve deeper insights with greater ease, facilitating high-value decisions faster than ever before.
